Skip to main content

Vaxcyte, Inc.

PCVX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001649094

In the last 90 days, Vaxcyte, Inc. insiders filed 0 open-market purchases and 8 sales; 331 institutions reported holding it in 13F filings for Q2 2026, worth $9.71B in total; Maverick Capital is the only superinvestor holding it.

Q3 2022 vs. Q2 2022

How the institutions holding Vaxcyte, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of PCVX: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders106126+20
Shares51.4M56.5M+5.05M (+9.8%)
Value$1.12B$1.36B+$237.0M (+21.2%)

New holders (26)

Institutions that held Vaxcyte, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to PCVX in Q3 2022
InstitutionSharesValue% of portfolio
National Bank of Canada885,538$21.3M0.12%
Avidity Partners Management LP628,700$15.1M0.33%
Capital Research Global Investors514,856$12.7M0.00%
Point72 Asset Management, L.P.422,800$10.1M0.04%
Vivo Capital, LLC404,508$9.71M1.07%
Acuta Capital Partners, LLC85,000$2.04M0.91%
Tri Locum Partners LP79,411$1.91M0.54%
Caption Management, LLC58,600$1.41M0.25%
Endurant Capital Management LP52,309$1.25M0.41%
Public Employees Retirement Association of Colorado38,961$935.0K0.01%
Martingale Asset Management L P33,513$806.0K0.02%
Schonfeld Strategic Advisors LLC22,979$551.0K0.00%
J. Goldman & Co LP21,168$508.0K0.04%
Penn Mutual Asset Management, LLC15,585$374.0K0.49%
Chicago Partners Investment Group LLC6,402$278.0K0.02%
Teacher Retirement System of Texas11,391$273.0K0.00%
Arizona State Retirement System9,508$228.0K0.00%
Balyasny Asset Management LLC9,417$226.0K0.00%
AQR Capital Management LLC9,326$224.0K0.00%
Walleye Trading LLC9,043$217.0K0.01%
Squarepoint Ops LLC9,043$217.0K0.00%
China Universal Asset Management Co., Ltd.555$13.0K0.01%
US Bancorp110$3.00K0.00%
Ronald Blue Trust, Inc.46$1.00K0.00%
Bell Investment Advisors, Inc28$1.00K0.00%
Parallel Advisors, LLC11$00.00%

Sold out (6)

Institutions that held Vaxcyte, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of PCVX in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Ikarian Capital, LLC225,991$4.92M
Gyon Technologies Capital Management, LP27,105$590.0K
Boothbay Fund Management, LLC22,733$495.0K
Trexquant Investment LP16,851$367.0K
Qube Research & Technologies Ltd13,820$301.0K
Voloridge Investment Management, LLC12,475$271.0K